INTRODUCTION
The World Health Organization estimates place the number of snake bites to be 421,000 envenoming and 20,000 deaths occur worldwide from snake bite each year, but warn that these figures may be as high as 1,841,000 envenoming and 94,000 deaths per annum. [1] In India, an estimated 200,000 persons per year fall prey to snake bite, with an estimated mortality rate of 35,000-50,000 per year. India is the country to have the highest level of mortality from snake bites worldwide. [2, 3] In India, there are 216 species of snakes, although only four of these are venomous (cobra, krait, Russell's viper, and saw scaled viper). [4] Most fatalities occur due to the victim not reaching the hospital in sufficient time for treatment to be administered. In addition, local communities are typically not well informed about the occupational risks and simple measures, which can prevent bites. Furthermore, harmful first aid practices such as tourniquets, cutting, and suction; continue to be frequently employed, and studies have revealed that primary care doctors are reluctant to treat snake bite patients, mainly due to lack of confidence. [5] India is thought to have more snake bites than any other country, [6] but the incidence and frequency of snake bites varies across the different geographic regions within the country depending on factors such as climate, ecology, biodiversity, distribution of snakes, and the density of the human population. [7] Based on an epidemiological survey conducted by Hati et al. in 1992 , [8] in 26 villages of Burdwan district, West Bengal, annually, nearly 0.16%/year of the total population experienced a snake bite, with a resulting mortality rate of 0.016%/year were observed, while in Maharashtra an incidence rate of 70 bites per 100,000 population and a mortality rate of 2.4 per 100,000/year has been reported. [9] Other states in India that show high incidences include Tamil Nadu, Uttar Pradesh, and Kerala. [10] Snake bite is an important and serious medical problem in many parts of India. Reliable data for levels of morbidity and mortality are not available, however, since there is no proper reporting system. Moreover, the records of a large number of cases do not appear in official statistics since people often seek traditional methods of treatment. [11] Indeed, it would appear that delayed presentation to hospitals frequently contributes to increased morbidity and mortality from snake bites. [12] Overall, this means that there are very few epidemiological studies of snake bites in India, and most research has tended to deal with clinical and management aspects of the problem. [11] In this context, the objective of our study was to determine the sociodemographic profile and the management of snake bite cases admitted to the Kempegowda Institute of Medical Sciences (KIMS) Hospital and research center, Bengaluru. This is one of the oldest multi-specialty tertiary care hospital situated in the heart of the city of Bengaluru city and having 810 beds and a well-equipped emergency department and critical care units. The wide range of specialists in the hospital is able to provide safe, excellent, patient care for emergency cases like snake bites.
MATERIALS AND METHODS
A hospital based retrospective descriptive study was carried out using records between January 2008 and December 2011 from the medical records department of KIMS Hospital and Research Center, Bengaluru. A total of 93 cases of snake bite were found to have been admitted during the study period. Patient data relevant to the study, such as patient demographics, treatment details, admission, and duration of hospital stay were obtained from the patient data collection case sheet and treatment charts, and this information was documented on a suitably designed patient data collection form and then analyzed manually using MS Excel 2007 software.
RESULTS AND DISCUSSION
Snake bite is a significant public health problem in many countries, with large numbers of envenomings and fatalities, although it is difficult to define the actual number of snake bite victims. [13] An accurate measure of the global burden of snake bite envenoming remains elusive despite several attempts to estimate it and apart from a few countries, reliable figures on incidence, morbidity, and mortality are scarce. [14] Hospital studies are a key source of information about snake bites, however, in our hospital-based retrospective descriptive study, we observed that the proportional case rate of snake bite was 1.33/1000 admissions in the year 2008, 1.32/1000 admissions in 2009, 2.6/1000 admissions in 2010, and 1.27/1000 admission in 2011, respectively. A total of 93 cases of snake bite poisoning were admitted to KIMS Hospital Bengaluru during the study period. There were 66 (70.96%) males and 27 (29.03%) females, giving a male-female ratio of 2.4:1 [Chart 1]. Our study subjects were between the ages of 1.6 years and 72 years. The majority (24.7%) of cases, however, were found to be between the ages of 19 and 30 years [ Table 1 ]. The Chart 1: Gender distribution of the patient study hospitalization time for the snake bite cases in our study varied between 1 and 66 days, with the average duration of hospital stay being 12.64 days [ Table 2 ]. The majority of our subjects (78: 83.8%) were from rural areas. Our study showed that snake bite was commonly seen among laborers and agricultural workers, and the majority of cases were observed during the rainy season; a period of intense agricultural activity. Young men are more frequently affected and generally bites occur in the lower limbs. The incidence and mortality from snake bite also increase sharply during extreme weather events such as floods. [14] Assessing the history of snake bite patients initially brought to the emergency department of our hospital, for most patients, treatment was started immediately with ventilation support. During the management of snake bite, 74.1% (69) subjects received anti-snake venom (ASV), followed by drugs such as antibiotics, anti-ulcer, analgesic/antipyretics, antihistamine, and adjuvant therapy [Chart 2]. About 87 (93.5%) of the cases resulted in relief or cure, and there were six fatalities (6.5%).
A widespread belief in the society is that all snake bites inevitably result in envenoming. In reality, however, bites by nonvenomous snakes are common, and bites by venomous species are not always accompanied by the injection of venom (dry bites). When envenoming does occur, it can rapidly become life-threatening. Snake venom is a complex mixture of toxins and enzymes, each of which may be responsible for one or more distinct toxic actions. In bites by South Asian viperid snakes, for example, envenoming results in local pain and tissue damage, characterized by swelling, blistering, bleeding, and necrosis at the site of the bite, sometimes extending to the whole limb. [15] Viperid venoms can also induce coagulopathy and platelet dysfunction, leading to spontaneous systemic hemorrhages and persistent bleeding from fang marks, wounds or gums. Intracranial bleeding, including anterior pituitary hemorrhage and multiple organ failure are common causes of death. [16] Among the Elapidae, bites by Naja naja and Naja kaouthia can cause significant local swelling and sometimes extensive tissue necrosis of the bitten limb, whereas bites by kraits or sea snakes do not usually cause signs of local envenoming and can be virtually painless. Cobra venom contains mainly postsynaptic neurotoxins, which bind and block the acetylcholine receptors of the neuromuscular junction while krait venom, in addition, contains presynaptic toxins that damage nerve endings. [14] Many medically important venomous snakes belong to complex groups of similar species or subspecies. Examples include the Asiatic cobras (N. naja species group), the Echis carinatus species complex, the fer-de-lance (Bothrops utrox) group, the Australian brown snakes (Pseudonaju spp.), and the sub species of the neo tropical rattle snake (Crotulus durissus). In some of these groups, the species or subspecies are very poorly defined and may represent artificial entities made up of heterogeneous groups of populations. Understanding the systematics of such groups is important for toxicology and clinical science, [17] The management of envenomed snake bites is not limited to the administration of anti-venoms. In the case of neurotoxic envenoming, artificial ventilation and careful airway management are crucial to avoid asphyxiation in patients with respiratory paralysis. Cases of complete recovery from severe neuromuscular paralysis without anti-venom have been reported after prolonged artificial ventilation. [18] A few cases of successful anticholinesterase use have also been reported in krait bite envenoming in India. [19] Bacterial infections can develop at the bite site, especially if the wound has been incised or tampered with using nonsterile instruments, and these may require antibiotic treatment. Currently, however, there is no data supporting their systematic use. [20] Anti-snake venom is an immunoglobulin (usually the enzyme refined F(ab)2 fragment of IgG) purified from the serum or plasma of a horse or sheep that has been immunized with the venoms of one or more species of snakes. Anti-venoms may be species specific (monovalent) or effective against several species (polyvalent), usually the most important species from a medical point of view, in a particular geographical area. The correct use of anti-venom is the most important component of hospital care, although not every bite merits its use. Administration of anti-venom should be selective and based on the severity of the clinical symptoms. The main concern about the empirical use of anti-venom is the risk of allergic reaction, its relative scarcity in some centers and the cost factor. [21] The potential for mortality and the finely balanced medical judgments that need to be made when treating snake bites (as described above) argue for more effort to be devoted to encouraging effective first aid and then rapid hospitalization of victims of snake bite. Improving the knowledge of caregivers and local communities is crucial in this. Health workers are usually poorly trained to deal with this complex emergency. Education of local communities on snake bites, avoidance of useless or dangerous first-aid measures, and the importance of the rapid transfer of victims to treatment centers should be widely implemented to reduce morbidity and mortality. In fact, the time taken to reach a hospital has been shown to be a crucial determinant of snake bite mortality and delayed anti-venom administration was associated with an increased risk of complications. [23, 24] Education should focus on the following key points: The bite victim should be reassured, the bitten limb immobilized with a makeshift splint or sling, and the patient transported. Walking is contraindicated because muscular contractions promote venom absorption. These simple recommendations are unfortunately rarely followed and vital time is often lost. The majority of victims first report to traditional healers. Popular traditional treatments include chanting, incisions, attempts to suck the venom from the bite site, and the application of herbal medicine or snake stones. [14] CONCLUSION Snake bite is a neglected, life-threatening emergency in developing countries such as India and demands immediate anti-venom therapy. It is a disease of poverty, endemic to farming regions. There is a need for the enactment of a national programmed aimed at the preventions of snakes and improving the quality of care and health education.
In this study, snake bites were more often seen among adults, male agricultural laborers and farmers, with a peak occurrence during rainy seasons. Knowledge • Pregnant women, small children. [22] of the varied clinical manifestations of snake bite is important for effective management in hospitals by a complete health care team. The ready availability and appropriate use of ASV, close monitoring of patients, the institution of ventilator support and if required, early referral to a larger hospital all help to reduce the mortality.
A clinical pharmacist as a vital member of a health care team and a key person in drug and poison information centers (PIC), who should be familiar with current snake bite treatments, both local and systemic, and should be prepared to provide important information and dispel any myths about snake bite poisoning. Establishing a PIC, this should be networked with other PICs in India and also with developed countries, can help in the early identification of poisoning and can also improve case management by enabling the sharing of information.
